Skip Nav Destination
Issues
1 February 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Highlights
Minireview
Reviews
Research Articles
Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway
Federico Rojo; Laia Domingo; Maria Sala; Sandra Zazo; Cristina Chamizo; Silvia Menendez; Oriol Arpi; Josep Maria Corominas; Rafael Bragado; Sonia Servitja; Ignasi Tusquets; Lara Nonell; Francesc Macià; Juan Martínez; Ana Rovira; Joan Albanell; Xavier Castells
Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer Subtypes
Mariana Chavez-MacGregor; Shuying Liu; Debora De Melo-Gagliato; Huiqin Chen; Kim-Anh Do; Lajos Pusztai; W. Fraser Symmans; Lakshmy Nair; Gabriel N. Hortobagyi; Gordon B. Mills; Funda Meric-Bernstam; Ana M. Gonzalez-Angulo
Serum Levels of Cytokines and Biomarkers for Inflammation and Immune Activation, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk
Elena Vendrame; Shehnaz K. Hussain; Elizabeth Crabb Breen; Larry I. Magpantay; Daniel P. Widney; Lisa P. Jacobson; Daina Variakojis; Emilee R. Knowlton; Jay H. Bream; Richard F. Ambinder; Roger Detels; Otoniel Martínez-Maza
Short Communications
Author Choice
Associations between Cigarette Smoking, Hormone Therapy, and Folate Intake with Incident Colorectal Cancer by TP53 Protein Expression Level in a Population-Based Cohort of Older Women
Lori S. Tillmans; Robert A. Vierkant; Alice H. Wang; N. Jewel Samadder; Charles F. Lynch; Kristin E. Anderson; Amy J. French; Robert W. Haile; Lisa J. Harnack; John D. Potter; Susan L. Slager; Thomas C. Smyrk; Stephen N. Thibodeau; James R. Cerhan; Paul J. Limburg
Null Results in Brief
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.